JP2016500671A5 - - Google Patents

Download PDF

Info

Publication number
JP2016500671A5
JP2016500671A5 JP2015535846A JP2015535846A JP2016500671A5 JP 2016500671 A5 JP2016500671 A5 JP 2016500671A5 JP 2015535846 A JP2015535846 A JP 2015535846A JP 2015535846 A JP2015535846 A JP 2015535846A JP 2016500671 A5 JP2016500671 A5 JP 2016500671A5
Authority
JP
Japan
Prior art keywords
pyridin
fluoro
methylphenyl
pyridine
imidazo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015535846A
Other languages
English (en)
Japanese (ja)
Other versions
JP6457942B2 (ja
JP2016500671A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/063585 external-priority patent/WO2014055955A1/en
Publication of JP2016500671A publication Critical patent/JP2016500671A/ja
Publication of JP2016500671A5 publication Critical patent/JP2016500671A5/ja
Application granted granted Critical
Publication of JP6457942B2 publication Critical patent/JP6457942B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015535846A 2012-10-05 2013-10-04 Gdf−8阻害剤 Expired - Fee Related JP6457942B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261710449P 2012-10-05 2012-10-05
US61/710,449 2012-10-05
PCT/US2013/063585 WO2014055955A1 (en) 2012-10-05 2013-10-04 Gdf-8 inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018207133A Division JP2019048841A (ja) 2012-10-05 2018-11-02 Gdf−8阻害剤

Publications (3)

Publication Number Publication Date
JP2016500671A JP2016500671A (ja) 2016-01-14
JP2016500671A5 true JP2016500671A5 (enExample) 2016-11-17
JP6457942B2 JP6457942B2 (ja) 2019-01-23

Family

ID=49474701

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015535846A Expired - Fee Related JP6457942B2 (ja) 2012-10-05 2013-10-04 Gdf−8阻害剤
JP2018207133A Pending JP2019048841A (ja) 2012-10-05 2018-11-02 Gdf−8阻害剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018207133A Pending JP2019048841A (ja) 2012-10-05 2018-11-02 Gdf−8阻害剤

Country Status (20)

Country Link
US (3) US9145433B2 (enExample)
EP (1) EP2903978B1 (enExample)
JP (2) JP6457942B2 (enExample)
KR (1) KR20150072412A (enExample)
CN (1) CN104837832B (enExample)
AU (1) AU2013326867B2 (enExample)
BR (1) BR112015007182A2 (enExample)
CA (1) CA2887203A1 (enExample)
CL (1) CL2015000851A1 (enExample)
EA (1) EA201590693A1 (enExample)
IL (1) IL238031A0 (enExample)
MA (1) MA38050B1 (enExample)
MX (1) MX2015004151A (enExample)
PE (1) PE20150767A1 (enExample)
PH (1) PH12015500719A1 (enExample)
SA (1) SA515360229B1 (enExample)
SG (1) SG11201502527UA (enExample)
TN (1) TN2015000121A1 (enExample)
WO (1) WO2014055955A1 (enExample)
ZA (1) ZA201503041B (enExample)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2887203A1 (en) * 2012-10-05 2014-04-10 Rigel Pharmaceuticals, Inc. 2,3-(hetero)aryl substituted pyridinyl compounds and their use as gdf-8 inhibitors
TWI664164B (zh) 2014-02-13 2019-07-01 美商英塞特控股公司 作為lsd1抑制劑之環丙胺
PE20161573A1 (es) 2014-02-13 2017-01-19 Incyte Corp Ciclopropilamina como inhibidor de la lsd1
WO2015123437A1 (en) 2014-02-13 2015-08-20 Incyte Corporation Cyclopropylamines as lsd1 inhibitors
US10233170B2 (en) 2014-04-08 2019-03-19 Rigel Pharmaceuticals, Inc. 2,3-disubstituted pyridine compounds as TGF-beta inhibitors and methods of use
CA2944697C (en) 2014-04-22 2022-07-19 Universitaet Basel Manufacturing process for triazine, pyrimidine and pyridine derivatives
CN103965192B (zh) * 2014-05-20 2016-01-13 定陶县友帮化工有限公司 一种6-氯咪唑并[1,2-a]吡啶-3-甲酸的合成方法
CN103965190A (zh) * 2014-05-20 2014-08-06 定陶县友帮化工有限公司 一种咪唑并[1,2-a]吡啶-3-甲酸的合成方法
CN103965191A (zh) * 2014-05-20 2014-08-06 定陶县友帮化工有限公司 一种6-溴咪唑并[1,2-a]吡啶-3-甲酸的合成方法
CA2953177C (en) 2014-06-23 2019-07-23 Dr. Reddy's Laboratories Ltd. Substituted imidazo[1,2-a]pyridine compounds useful for the treatment of pain
US9695168B2 (en) 2014-07-10 2017-07-04 Incyte Corporation Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as LSD1 inhibitors
US9695180B2 (en) 2014-07-10 2017-07-04 Incyte Corporation Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors
WO2016007722A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Triazolopyridines and triazolopyrazines as lsd1 inhibitors
CN104402881B (zh) * 2014-11-05 2016-04-20 定陶县友帮化工有限公司 一种3-醛基-6-溴咪唑并[1,2-a]吡啶-8-甲酸乙酯的合成方法
JP6800158B2 (ja) * 2015-02-20 2020-12-16 ライジェル ファーマシューティカルズ, インコーポレイテッド Gdf−8阻害剤
KR20170122799A (ko) 2015-03-02 2017-11-06 리겔 파마슈티칼스, 인크. TGF-β 억제제
MY191796A (en) 2015-04-03 2022-07-15 Incyte Corp Heterocyclic compounds as lsd1 inhibitors
RS62639B1 (sr) 2015-07-06 2021-12-31 Alkermes Inc Hetero-halo inhibitori histonskih deacetilaza
EP3319968A1 (en) 2015-07-06 2018-05-16 Rodin Therapeutics, Inc. Heterobicyclic n-aminophenyl-amides as inhibitors of histone deacetylase
KR102710120B1 (ko) 2015-08-12 2024-09-27 인사이트 홀딩스 코포레이션 Lsd1 저해제의 염
CA2995997A1 (en) 2015-08-26 2017-03-02 Blueprint Medicines Corporation Compounds and compositions useful for treating disorders related to ntrk
KR20180081790A (ko) 2015-11-19 2018-07-17 블루프린트 메디신즈 코포레이션 Ntrk 관련 장애의 치료에 유용한 화합물 및 조성물
EP4050005B1 (en) * 2015-11-25 2024-12-25 Convergene Llc Bicyclic bet bromodomain inhibitors and uses thereof
US11352328B2 (en) 2016-07-12 2022-06-07 Arisan Therapeutics Inc. Heterocyclic compounds for the treatment of arenavirus
MD3496739T2 (ro) 2016-07-15 2021-09-30 Acceleron Pharma Inc Compoziții care cuprind polipeptide actriia pentru utilizarea în tratarea hipertensiunii pulmonare
WO2018017633A1 (en) 2016-07-21 2018-01-25 Bristol-Myers Squibb Company TGF Beta RECEPTOR ANTAGONISTS
WO2018019106A1 (zh) * 2016-07-29 2018-02-01 上海璎黎药业有限公司 含氮芳香杂环化合物、其制备方法、药物组合物和应用
US10280164B2 (en) 2016-09-09 2019-05-07 Incyte Corporation Pyrazolopyridone compounds and uses thereof
US20180072741A1 (en) 2016-09-09 2018-03-15 Incyte Corporation Pyrazolopyrimidine compounds and uses thereof
WO2018049214A1 (en) 2016-09-09 2018-03-15 Incyte Corporation Pyrazolopyridine derivatives as hpk1 modulators and uses thereof for the treatment of cancer
KR20230038807A (ko) 2016-09-09 2023-03-21 인사이트 코포레이션 Hpk1 조절제로서의 피라졸로피리딘 유도체 및 암의 치료를 위한 이의 용도
WO2018081313A1 (en) 2016-10-25 2018-05-03 Elevation Spine, Inc. Intervertebral implant and method of use
US10961239B2 (en) 2017-01-05 2021-03-30 Bristol-Myers Squibb Company TGF beta receptor antagonists
JP6756925B2 (ja) 2017-01-11 2020-09-16 ロダン・セラピューティクス,インコーポレーテッド ヒストンデアセチラーゼの二環式阻害剤
US20180228786A1 (en) 2017-02-15 2018-08-16 Incyte Corporation Pyrazolopyridine compounds and uses thereof
US10631999B2 (en) 2017-06-30 2020-04-28 Elevation Spine, Inc. Systems and methods for inserting an interbody spacer and bone plate assembly
ES2914355T3 (es) 2017-08-07 2022-06-09 Alkermes Inc Inhibidores bicíclicos de la histona desacetilasa
US10722495B2 (en) 2017-09-08 2020-07-28 Incyte Corporation Cyanoindazole compounds and uses thereof
HUE059624T2 (hu) 2018-02-20 2022-11-28 Incyte Corp N-(fenil)-2-(fenil)pirimidin-4-karboxamid származékok és rokon vegyületek HPK1-inhibitorokként rák kezelésére
US10752635B2 (en) 2018-02-20 2020-08-25 Incyte Corporation Indazole compounds and uses thereof
US10745388B2 (en) 2018-02-20 2020-08-18 Incyte Corporation Indazole compounds and uses thereof
US11299473B2 (en) 2018-04-13 2022-04-12 Incyte Corporation Benzimidazole and indole compounds and uses thereof
US10899755B2 (en) 2018-08-08 2021-01-26 Incyte Corporation Benzothiazole compounds and uses thereof
US10968200B2 (en) 2018-08-31 2021-04-06 Incyte Corporation Salts of an LSD1 inhibitor and processes for preparing the same
WO2020068729A1 (en) 2018-09-25 2020-04-02 Incyte Corporation Pyrazolo[4,3-d]pyrimidine compounds as alk2 abd/or fgfr modulators
US12419865B2 (en) 2018-12-06 2025-09-23 Arisan Therapeutics Inc. Compounds for the treatment of arenavirus infection
US12247015B2 (en) 2019-04-29 2025-03-11 Solent Therapeutics, Llc 3-amino-4H-benzo[e][1,2,4]thiadiazine 1,1-dioxide derivatives as inhibitors of MRGX2
PH12022550271A1 (en) 2019-08-06 2023-06-26 Incyte Corp Solid forms of an hpk1 inhibitor
CN112225736B (zh) * 2020-11-12 2022-04-15 山东省科学院菏泽分院 一种6-溴咪唑并[1.2-a]吡啶-3-甲醛的制备方法
EP4457222A2 (en) 2021-12-28 2024-11-06 EmpathBio, Inc. Nitric oxide releasing prodrugs of mda and mdma
IL313713A (en) * 2022-01-07 2024-08-01 Horizon Therapeutics Ireland Dac Heterocyclic inhibitors of glut9 for treatment of disease
KR102879073B1 (ko) * 2022-09-02 2025-10-31 단국대학교 천안캠퍼스 산학협력단 트리플루오로메틸페닐 티아디아진계 화합물 및 이를 유효성분으로 포함하는 근감소증 예방 또는 치료용 조성물
CN117049961A (zh) * 2023-08-16 2023-11-14 苏州君叶生物医药科技有限公司 一种酵母脱氢酶抑制剂的衍生物及其合成方法

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW458977B (en) * 1997-04-16 2001-10-11 Abbott Lab 6,7-disubstituted-4-aminopyrido[2,3-D] pyrimidine compounds
WO2000040243A1 (en) 1999-01-08 2000-07-13 Smithkline Beecham Corporation Novel compounds
BR0008188A (pt) 1999-01-21 2002-02-13 Metamorphix Inc Inibidores de fator de diferenciação de crescimento e usos para os mesmos
JP2001081087A (ja) * 1999-09-13 2001-03-27 Sankio Chemical Co Ltd 新規な2−(2−ピリジル)ピリミジン誘導体
WO2001057040A1 (en) * 2000-02-03 2001-08-09 Abbott Laboratories 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
CN1446202A (zh) * 2000-08-11 2003-10-01 卫材株式会社 2-氨基吡啶化合物及其作为药物的用途
AU2001295026B2 (en) * 2000-09-06 2008-04-03 Novartis Vaccines And Diagnostics, Inc. Inhibitors of glycogen synthase kinase 3
US7320789B2 (en) 2001-09-26 2008-01-22 Wyeth Antibody inhibitors of GDF-8 and uses thereof
MXPA04003445A (es) * 2001-10-15 2004-07-08 Du Pont Iminobenzoxazinas imnobenztiazinas e iminoquinazolinas para controlar pestes de invertebrados.
WO2003082191A2 (en) * 2002-03-28 2003-10-09 Merck & Co., Inc. Substituted 2,3-diphenyl pyridines
FR2856684B1 (fr) * 2003-06-26 2008-04-11 Sanofi Synthelabo Derives de diphenylpyridine, leur preparation et leur application en therapeutique
CA2535665A1 (en) 2003-08-14 2005-02-24 Asahi Kasei Pharma Corporation Substituted arylalkanoic acid derivative and use thereof
US7799772B2 (en) 2003-12-18 2010-09-21 Janssen Pharmaceutica N.V. Pyrido-and pyrimidopyrimidine derivatives as anti-profilerative agents
US20070185152A1 (en) * 2004-03-02 2007-08-09 Smithkline Beecham Corporation Inhibitors of akt activity
ES2241496B1 (es) * 2004-04-15 2006-12-01 Almirall Prodesfarma, S.A. Nuevos derivados de piridina.
US7777035B2 (en) 2005-06-22 2010-08-17 Chemocentryx, Inc. Azaindazole compounds and methods of use
EP1973914A2 (en) * 2005-12-22 2008-10-01 Biogen Idec MA Inc. Transforming growth factor modulators
EP2044056B1 (en) 2006-07-14 2012-08-22 Novartis AG Pyrimidine derivatives as alk-5 inhibitors
FR2904827B1 (fr) * 2006-08-11 2008-09-19 Sanofi Aventis Sa Derives de 5,6-bisaryl-2-pyridine-carboxamide, leur preparation et leur application en therapeutique comme antiganistes des recepteurs a l'urotensine ii
CA2667962A1 (en) 2006-10-30 2008-05-08 Novartis Ag Heterocyclic compounds as antiinflammatory agents
ES2303776B1 (es) * 2006-12-29 2009-08-07 Laboratorios Almirall S.A. Derivados de 5-fenil-6-piridin-4-il-1,3-dihidro-2h-imidazo(4,5-b)piridin-2-ona utiles como antagonistas del receptor de adenosina a2b.
WO2008094574A2 (en) * 2007-01-30 2008-08-07 Biogen Idec Ma Inc. Furanone compounds and methods of making and using the same
US8445679B2 (en) * 2007-04-16 2013-05-21 Abbvie Inc. 7-substituted indole MCL-1 inhibitors
EA201000123A1 (ru) 2007-07-26 2010-08-30 Новартис Аг Органические соединения
WO2009032653A1 (en) * 2007-08-31 2009-03-12 Smith Kline Beecham Corporation Inhibitors of akt activity
KR20100075881A (ko) 2007-08-31 2010-07-05 메르크 세로노 에스. 에이. 트리아졸로피리딘 화합물 및 ask 저해제로서 이의 용도
EP2211619A1 (en) * 2007-10-18 2010-08-04 Merck Sharp & Dohme Corp. Substituted 1,2,4-oxadiazoles and analogs thereof as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases
FR2927330B1 (fr) * 2008-02-07 2010-02-19 Sanofi Aventis Derives de 5,6-bisaryl-2-pyridine-carboxamide, leur preparation et leur application en therapeutique comme antagonistes des recepteurs a l'urotensine ii
KR101015858B1 (ko) * 2008-06-26 2011-02-23 제일모직주식회사 유기 화합물, 및 이를 포함하는 유기 광전 소자
US8501940B2 (en) * 2008-07-15 2013-08-06 Hoffmann-La Roche Inc. Tetrahydrocinnoline derivatives
EP2377907B1 (en) * 2008-12-30 2014-12-03 Cheil Industries Inc. Novel compounds for an organic photoelectric device, and organic photoelectric device comprising same
US8569316B2 (en) 2009-02-17 2013-10-29 Boehringer Ingelheim International Gmbh Pyrimido [5,4-D] pyrimidine derivatives for the inhibition of tyrosine kinases
JP2013515734A (ja) * 2009-12-23 2013-05-09 エラン ファーマシューティカルズ,インコーポレイテッド ポロ様キナーゼの阻害薬としてのプテリジノン
WO2011096196A1 (en) * 2010-02-02 2011-08-11 Oncotherapy Science, Inc. Lsd1 for target genes of cancer therapy and diagnosis
AU2010344973B2 (en) * 2010-02-05 2016-06-16 Merck Patent Gmbh Hetaryl-[1,8]naphthyridine derivatives
US8575203B2 (en) 2010-04-21 2013-11-05 Boehringer Ingelheim International Gmbh Chemical compounds
SG186871A1 (en) * 2010-07-05 2013-02-28 Merck Patent Gmbh Bipyridyl derivatives useful for the treatment of kinase - induced diseases
CA2887203A1 (en) * 2012-10-05 2014-04-10 Rigel Pharmaceuticals, Inc. 2,3-(hetero)aryl substituted pyridinyl compounds and their use as gdf-8 inhibitors

Similar Documents

Publication Publication Date Title
JP2016500671A5 (enExample)
KR101110530B1 (ko) 증식성 질환의 치료에 유용한 키나제 억제제
US9066954B2 (en) Fused heterocyclic derivatives and methods of use
JP5532398B2 (ja) 縮合複素環誘導体およびそれの使用方法
CA2733533C (en) Hedgehog pathway modulators
JP6457942B2 (ja) Gdf−8阻害剤
US9266881B2 (en) Triazolopyridinone PDE10 inhibitors
JP2014511884A5 (enExample)
EP3772513A1 (en) Shp2 inhibitors
JP2020514267A5 (enExample)
HRP20120105T1 (hr) Aminoheterociklički spojevi
RU2017105296A (ru) Новые соединения
WO2015171527A1 (en) Pyrazolopyridine pyrazolopyrimidine and related compounds
RU2017134901A (ru) Соединения 1-циано-пирролидинов в качестве ингибиторов USP30
JP2019535664A5 (enExample)
JP2017530960A5 (enExample)
JP2013508404A5 (enExample)
ME02330B (me) Derivati 2,3-dihidro-1h-inden-1-il-2,7-diazaspir0[3.6]nonana i njihova upotreba kao antagonista ili inverznih agonista grelinskog receptora
WO2022167682A1 (en) Azabicyclic shp2 inhibitors
WO2024238574A1 (en) Cdk inhibitor compounds
JP7539377B2 (ja) てんかん治療用複素環化合物
AU2005295091A1 (en) Substituted biaryl quinolin-4-ylamine analogues
JPWO2021194914A5 (enExample)
JPWO2020052631A5 (enExample)
JPWO2019198692A5 (enExample)